SVASE BIGs: Strategic Partnerships And Alliances For [Life Sciences And] Medtech Companies October 24, 2007

Date: Wednesday, October 24, 2007 At 06:00
Duration: 2 Hours 30 Minutes
Contact Info:
Cooley Godward Kronish LLP, 3175 Hanover Street, Palo Alto, CA 94304;
Contact Laura Weigant
Email: [email protected]
URL:svase.org/index.php?option=com_extcalendar&Itemid=149&extmode=view&extid=1120

As the overall costs associated with clinical development, regulatory approval process, and commercialization have steadily increased in the past several years, many [lifesciences and] medtech companies have utilized strategic partnerships and alliances as a means of defraying the costs, and potentially accelerating the timelines, associated with product development and commercialization. Alliances have also been formed to increase the sales and marketing reach and to capitalize upon new markets. These partnerships and alliances include a broad range of spectrum, from an early stage preclinical startup partnering with a multinational conglomerate to co-develop a new product, to established public companies cross licensing technology and entering into sales and marketing pacts.

The panel of experts will explore the key issues, pros and cons, trends and other considerations related to strategic partnerships and alliances, and share their experiences in an open round-table format. The following will be among the topics explored:

• What trends are we seeing?
• What successes & failures are we seeing?
• Are strategic partnerships really going to reduce costs & speed cycle times?
• What are the best reasons for considering partnerships?
• What are the worst reasons for considering partnerships?
• How do you assess the risks of a partnership, and how do you equitably share those risks?
• Best practices for Identifying and measuring key performance metrics
• Best practices for managing unforeseen problems?

Making the most of your strategic partnerships

What steps can you take in evaluating the pros and cons of partnerships you are considering, to give your alliances a higher probability of delivering the expected outcome? This informative and lively panel will explore these questions and more in an open, “round table” format to help you make the best assessment of your strategic partnership options.

The Panel:
• Phil Hopper, CEO, M2 Medical
• Tim Mill, Managing Director, Sanderling Ventures
• Dinesh V. Patel, Ph.D., President & CEO, Arete Therapeutics

Moderator: Frank Rahmani, Partner, Cooley Godward Kronish LLP

WHEN: Wednesday, October 24
6:00 - 7:00 pm: Networking and Business Showcase
7:00 - 8:15 pm: Panel discussion and Q/A
8:15 - 8:30 pm: Additional networking

LOCATION:
Cooley Godward Kronish LLP, 3175 Hanover Street, Palo Alto, CA 94304

PRE-REGISTERED RATES (All Rates Include Hors D’oeuvres):
Members - $20; Affiliates who advertise this event - $29; General Public - $49;
Business Showcase Exhibit Table – member rate: $149; non-member rate: $500
(Includes exhibit table and two tickets to the event.)

WALK-IN RATES: Add $10.00 to the listed price

Seating is limited, so early registration is recommended to avoid disappointment on the day.

This event is co-sponsored by Cooley Godward Kronish LLP. Cooley Godward Kronish LLP

See Website for Speaker Bios

Official Website: http://svase.org/index.php?option=com_extcalendar&Itemid=149&extmode=view&extid=1120